Medical Equipment

The Cell-Free DNA (cfDNA) Blood Collection Tube Market Is Advancing With Support From Surge In Respiratory Disorder Cases Fueling The Growth Of The Market Due To Rising Air Pollution And Hospitalizations

May 11, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Forecasted Rise In Market Size Of The Cell-Free DNA (cfDNA) Blood Collection Tube Market During The Forecast Period?

The cell-free dna (cfdna) blood collection tube market size has observed rapid expansion over recent years. It is anticipated to increase from $1.33 billion in 2025 to $1.51 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.6%. This historical growth can be linked to factors like the rising demand for prenatal testing, the expansion of cancer diagnostics, the integration of cfDNA into research, an increase in laboratory automation, and the broadening of diagnostic centers.

The cell-free dna (cfdna) blood collection tube market size is forecast to grow significantly in the coming years, reaching $2.49 billion by 2030 with a compound annual growth rate (CAGR) of 13.3%. This expansion during the forecast period is driven by innovations in blood tube preservatives, the integration of AI diagnostics, the flourishing liquid biopsy market, an increase in clinical trials, and growing demand within emerging markets. Notable trends anticipated include improvements in sample preservation, seamless integration with liquid biopsy platforms, the implementation of standardized blood collection protocols, increased automation in sample processing, and the development of high-stability tube designs.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28160&type=smp

Which Drivers Are Advancing The Cell-Free DNA (cfDNA) Blood Collection Tube Market Growth?

The occurrence of a rising number of respiratory illnesses is anticipated to propel the expansion of the cell-free DNA (cfDNA) blood collection tube market in the coming years. These medical conditions, which impact the lungs and other elements of the respiratory system, hinder efficient breathing, oxygen delivery to the blood, and carbon dioxide removal from the body. A primary factor contributing to this increase in respiratory disorders is air pollution, which irritates air passages, diminishes lung capacity, and heightens the likelihood of conditions such as asthma, bronchitis, and chronic obstructive pulmonary disease (COPD). Cell-free DNA (cfDNA) blood collection tubes are instrumental in managing these disorders by enabling the detection of genetic mutations, tracking disease progression, and evaluating treatment efficacy via a straightforward blood test, thus lessening the necessity for invasive lung biopsies. As an illustration, in December 2024, data from the Centers for Disease Control and Prevention, a US-based government agency, indicated that approximately 17,000 to 34,000 hospitalizations resulted from respiratory syncytial virus (RSV) between October 1 and November 30, 2024. Consequently, the growing frequency of respiratory disorders is fueling the expansion of the cell-free DNA (cfDNA) blood collection tube market. The rising occurrence of cancer is projected to foster the expansion of the cell-free DNA (cfDNA) blood collection tube market in the future. The uptick in cancer cases is linked to lifestyle elements such as inadequate diet, tobacco use, and insufficient physical activity. Cell-free DNA (cfDNA) blood collection tubes play a crucial role in cancer care by enabling liquid biopsies, which facilitate the identification of genetic mutations associated with tumors, tracking the advancement of the disease, evaluating the effectiveness of treatments, and pinpointing resistance mutations through a straightforward blood test, thereby diminishing the necessity for invasive tissue biopsies. For example, in May 2024, the National Cancer Institute, a US-based government agency, predicted that the count of cancer survivors within the United States would rise to 26 million by 2040, an increase from 18.1 million recorded in 2022. Hence, the escalating incidence of cancer is a key factor propelling the development of the cell-free DNA (cfDNA) blood collection tube market.

How Is Segment Classification Applied In The Cell-Free DNA (cfDNA) Blood Collection Tube Market?

The cell-free dna (cfdna) blood collection tube market covered in this report is segmented –

1) By Type: 5ml, 10ml

2) By Sample Type: Plasma, Serum, Whole Blood

3) By Application: In Vitro Diagnostics, Scientific Research

4) By End-User: Diagnostic Laboratories, Hospitals Or Clinical Centers, Genetic Diagnostic Labs, Cancer Research Centers, Research And Development Institutions, Conventional Diagnostic Centers

Subsegments:

1) By 5 mL: Single Use Tube, Vacuum Blood Collection Tube, Gel Separator Tube

2) By 10 mL: Double Draw Tube, High Volume Collection Tube, Anticoagulant Treated Tube

What Trends Are Shaping The Cell-Free DNA (cfDNA) Blood Collection Tube Market Structure?

Major companies in the cell-free DNA (cfDNA) blood collection tube market are prioritizing the automation of cfDNA extraction to improve workflow efficiency. This automation involves using advanced robotic instruments and standardized protocols to isolate cell-free DNA from blood samples with minimal manual intervention, which boosts efficiency, accuracy, and consistency while reducing turnaround time and human error. For instance, in September 2023, Yourgene Health plc, a UK-based molecular diagnostics company, introduced the MagBench Automated DNA Extraction Instrument and Kit. This offering provides a fast, simple, and cost-efficient bench-top robotic solution specifically optimized for cell-free DNA extraction in non-invasive prenatal testing (NIPT) workflows. The goal of this launch is to enhance automation in NIPT workflows by delivering greater throughput, reproducibility, and reliability in cfDNA extraction, simultaneously decreasing hands-on time and operational costs.

Which Key Players Are Active In The Cell-Free DNA (cfDNA) Blood Collection Tube Market?

Major companies operating in the cell-free dna (cfdna) blood collection tube market are Roche Holding AG, Thermo Fisher Scientific Inc., Becton Dickinson (BD), Qiagen N.V., SARSTEDT AG & Co. KG, Guangzhou Improve Medical Technology, Streck Inc., DiaCarta Inc., Zymo Research Corporation, Biomatrica Inc., PreAnalytiX GmbH, Beijing Cowin Bioscience Co.Ltd., Norgen Biotek Corporation, Nonacus Limited, Guangdong Ardent Biomed Co. Ltd, MagBio Genomics Inc., VanGenes, BEAVER, Hebei Xinle Science & Technology Co. Ltd., Nasmed Diagnostics Pvt. Ltd.

Access The Complete Cell-Free DNA (cfDNA) Blood Collection Tube Market Report:

https://www.thebusinessresearchcompany.com/report/cell-free-dna-cfdna-blood-collection-tube-global-market-report

Which Region Is The Primary Market For The Cell-Free DNA (cfDNA) Blood Collection Tube Market?

North America was the largest region in the cell-free DNA (cfDNA) blood collection tube market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell-free dna (cfdna) blood collection tube market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Cell-Free DNA (cfDNA) Blood Collection Tube Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=28160&type=smp

Browse Through More Reports Similar to the Global Cell-Free DNA (cfDNA) Blood Collection Tube Market 2026, By The Business Research Company

Medical Skin Markers Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-skin-markers-global-market-report

Surface Vision And Inspection Market Report 2026

https://www.thebusinessresearchcompany.com/report/surface-vision-and-inspection-global-market-report

Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795